U.S. Markets

Merck (MRK) says Keytrdua lung is not the number one revenue generator anymore, future revenue increasingly expects from Adjuvant settings

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more